Corrected Count Increment (CCI) for Platelet Transfusion
The CCI is calculated as: CCI = [absolute platelet increment × body surface area (m²)] / [number of platelets transfused × 10¹¹], with a threshold of ≥5,000 at 1 hour post-transfusion defining an adequate platelet response 1.
The Formula and Calculation
The CCI standardizes platelet transfusion response by accounting for:
- Patient body surface area (BSA) in square meters
- Number of platelets transfused (expressed as × 10¹¹)
- Absolute platelet increment (post-transfusion count minus pre-transfusion count)
Practical Example
If transfusion of 4 × 10¹¹ platelets produces an increment of 40,000/μL in a patient with 2 m² body surface area:
- CCI = (40,000 × 2) / 4 = 20,000 1
This represents an excellent response, well above the threshold.
Timing of Post-Transfusion Count
Measure the platelet count at 10 minutes to 1 hour after transfusion completion 1. The 10-minute measurement is practical since the patient must be present when the transfusion finishes to switch IV bags, and yields identical results to the 1-hour count 1. Recent data confirms that CCI measured at 10-30 minutes provides comparable results to 1-hour measurements 2.
Threshold for Adequate Response
A CCI ≥5,000 at 1 hour defines a satisfactory platelet transfusion response, as established by the TRAP study and endorsed by ASCO guidelines 1. For 24-hour measurements, the threshold drops to ≥2,500 3.
Simplified Clinical Approach (When Platelet Counts Unavailable)
Since most centers don't routinely provide platelet counts of infused products, use these rough estimates as equivalent to CCI ≥5,000 1:
For Adults:
- Pooled platelet concentrates: Expect ~2,000/μL increment per unit
- Apheresis platelets: Expect ~10,000/μL increment per transfusion
- Based on average adult BSA of 1.76 m² and average platelet count of 0.7 × 10¹¹ per unit
For Children:
- Expected increment: ~3,500/m²/unit 1
Defining Platelet Refractoriness
Do not diagnose refractoriness after a single poor increment—patients may respond adequately to subsequent transfusions 1.
Criteria for Refractoriness:
- At least two consecutive ABO-compatible transfusions
- Platelets stored <72 hours
- Both with CCI <5,000 at 1 hour (or <2,500 at 24 hours)
- Only then investigate for alloimmunization or other causes 1
Critical Pitfalls to Avoid
ABO incompatibility matters: ABO-incompatible platelets (e.g., group A platelets to group O recipients) can compromise post-transfusion increments 1. Always use ABO-compatible products when assessing refractoriness.
Non-immune causes of poor increments are common and include:
- Hypersplenism
- Severe disseminated intravascular coagulation (DIC)
- Shock
- Massive hemorrhage
- Drug-related antibodies
- Sepsis and fever 1
Only ~8-14% of refractory cases are due to alloimmunization when using leukoreduced products 1, so investigate clinical factors first before assuming immune refractoriness.
When to Monitor CCI
Obtain post-transfusion counts:
- After all transfusions to outpatients
- In non-bleeding hospitalized patients when day-to-day increments are unsatisfactory
- When patients remain at or below the trigger threshold after transfusion 1
This monitoring allows you to determine adequacy of therapy and identify refractoriness early, preventing continued hemorrhagic risk from inadequate platelet support.